ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Investors seek drugmakers in rush to treat coronavirus

Generic antivirals may help while medics scramble to develop vaccine

Investors are eagerly seeking out companies that may be able to develop and market treatments for the new coronavirus.   © Reuters

TOKYO -- The hunt for medicines and vaccines to halt the spread of coronavirus in China and other countries has sparked another search. Investors are eagerly seeking out companies that could develop and market treatments.

Stock markets in the U.S. and Asia have already seen flurries of excitement over companies that are either working on vaccines, or already produce medicines that may help patients infected with the virus. Some biotechnology companies have jumped in value, along with pharmaceuticals groups making retroviral drugs.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more